Four Life Domains Vision Board Program

Brief summary (registry, in English)

This randomized controlled trial aims to evaluate the effect of a Four Life Domains-Based Vision Board Program on hope and psychological resilience among adolescents undergoing cancer treatment. Adolescents receiving cancer treatment often experience psychological distress that may negatively affect their sense of hope and resilience. Vision board-based psychosocial interventions grounded in positive psychology and creative expression may support adaptive coping and emotional well-being. The study will be conducted in pediatric hematology-oncology units of Gazi University Health Application and Research Center and Etlik City Hospital in Türkiye. A total of 60 adolescents aged 12-18 years who have been receiving cancer treatment for at least six months will be randomly assigned to either the intervention group (n=30) or the control group (n=30). Participants in the intervention group will receive a structured 5-week Four Life Domains-Based Vision Board Program, consisting of four core modules and one reinforcement session, while the control group will receive standard hospital care only. Outcome measures, including hope and psychological resilience, will be assessed at baseline and after completion of the intervention. The findings are expected to contribute to the development of innovative and holistic psychosocial support interventions for adolescents undergoing cancer treatment.

What you commit to

• Study type: Interventional
• Planned participants: 60
• From 30 Jan 2026 to the primary completion date, 20 Mar 2027
• No sites listed in no country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov